Vida Ventures Advisors, LLC - DYNE THERAPEUTICS INC ownership

DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 103 filers reported holding DYNE THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.7%.

Quarter-by-quarter ownership
Vida Ventures Advisors, LLC ownership history of DYNE THERAPEUTICS INC
ValueSharesWeighting
Q4 2023$27,594,667
+38.7%
2,074,787
-6.5%
32.85%
+6.7%
Q3 2023$19,891,505
-20.4%
2,220,0340.0%30.79%
-5.6%
Q2 2023$24,975,383
-2.3%
2,220,0340.0%32.61%
-6.8%
Q1 2023$25,574,792
-0.6%
2,220,0340.0%34.99%
+1.2%
Q4 2022$25,730,194
-8.7%
2,220,0340.0%34.58%
+36.6%
Q3 2022$28,194,000
+38.6%
2,220,034
-25.0%
25.30%
+47.3%
Q2 2022$20,335,000
-28.7%
2,960,0460.0%17.18%
+3.5%
Q1 2022$28,535,000
-18.9%
2,960,0460.0%16.60%
+26.1%
Q4 2021$35,195,000
-26.8%
2,960,0460.0%13.16%
-4.4%
Q3 2021$48,071,000
-22.8%
2,960,0460.0%13.77%
-11.8%
Q2 2021$62,280,000
+35.5%
2,960,0460.0%15.62%
+34.5%
Q1 2021$45,970,000
-26.0%
2,960,0460.0%11.61%
-9.0%
Q4 2020$62,161,000
+4.0%
2,960,0460.0%12.76%
-65.9%
Q3 2020$59,764,0002,960,04637.43%
Other shareholders
DYNE THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 2,960,046$20,335,00017.18%
MPM ASSET MANAGEMENT LLC 4,951,303$34,015,00014.35%
Atlas Venture Life Science Advisors, LLC 8,934,902$61,383,00010.26%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 3,865$562,568,0005.87%
Logos Global Management LP 2,900,000$19,923,0003.66%
Deep Track Capital, LP 3,500,000$24,045,0001.58%
HighVista Strategies LLC 241,867$1,662,0001.00%
Monashee Investment Management LLC 319,536$2,195,0000.80%
RA Capital Management 2,805,045$19,271,0000.51%
Vivo Capital, LLC 577,642$3,968,0000.40%
View complete list of DYNE THERAPEUTICS INC shareholders